Biohit Oyj Class B's next confirmed earnings release is scheduled for February 17, 2027.
| Earnings Date | 2/17/2027 |
As of June 30, 2016, Biohit Oyj Class B has 14.70M shares outstanding.
| Shares Outstanding | 14.70M |
As of June 30, 2016, Biohit Oyj Class B maintains a current ratio of 6.56, meaning it holds 6.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 6.56 |
| Quick Ratio | 5.06 |
| Debt / Equity | 0.92 |
These figures cover the twelve months ended June 30, 2016.
| Employee Count | 50.00 |
Over the twelve months ended June 30, 2016, Biohit Oyj Class B recorded 14,000.00 in income tax expense.
| Income Tax | 14,000.00 |
As of the close on October 22, 2026, Biohit Oyj Class B's stock has declined approximately 31.49% over the past 52 weeks. The 50-day moving average sits at 2.54, while the 200-day moving average is 2.79.
| 52-Week Price Change | -31.49% |
| 50-Day Moving Average | 2.54 |
| 200-Day Moving Average | 2.79 |
As of June 30, 2016, Biohit Oyj Class B holds 8.10M in cash and equivalents against 100,000.00 in total debt, resulting in a net debt position of -400,000.00. Total book value stands at 10.90M, with working capital of 8.90M providing operational flexibility.
| Cash & Cash Equivalents | 8.10M |
| Total Debt | 100,000.00 |
| Net Debt | -400,000.00 |
| Equity (Book Value) | 10.90M |
| Book Value Per Share | 0.74 |
| Working Capital | 8.90M |
These figures cover the twelve months ended June 30, 2016.
| Capital Expenditures | -123,000.00 |
Already premium?